浸润性导管乳腺癌与浸润性小叶乳腺癌的鉴别诊断与预后评估

Differential Diagnosis and Prognosis of Infiltrating Ductal Breast Cancer and Invasive Lobular Breast

为了浸润性导管乳腺癌(IDC)与浸润性小叶乳腺癌(ILC)的鉴别诊断与预后评估,选取笔者所在医院2010年1月至2014年10月的350例IDC患者和40例ILC患者,分为两组,均进行了钼靶X线和超声检查,并进行24个月的随访。结果IDC组的钼靶X线和超声检出率均高于ILC组(P<0.05);两组肿瘤位置、多中心多灶性、同时性双乳癌发生率和雌激素受体(ER)阳性表达率都具有差异,IDC的两年内存活率明显高于ILC(P<0.05)。ILC的预后更差,病理学检查对乳腺癌分型可以使组织分型更准确,提高治疗效果,同时要注意ILC患者的保乳手术后的复发风险。

To evaluate the differential diagnosis and prognosis of infiltrating ductal breast cancer and invasive lobular breast cancer.350 patients with invasive ductal breast cancer and 40 patients with invasive lobular breast cancer were divided into two groups.The patients were divided into two groups：molybdenum target X-ray and ultrasonography.The detection rate of the IDC group of mammography and ultrasonography were higher than ILC group（P0.05）;two groups of tumor location,multicenter,multifocal,double breast cancer and the positive rate of ER has the difference rate,IDC two years survival rate was significantly higher than that of ILC（P0.05）.The prognosis of ILC is worse.The use of pathological examination of breast cancer classification can make the organization more accurate,improve the treatment effect,and should pay attention to the recurrence risk of ILC patients after breast conserving surgery.